Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
sabato, ottobre 24
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Kairos Pharma Ltd
KAPA
AMEX
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$0.5585
0.0145
2.67%
Ult. Agg.: Oct 23, 6:11 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Rapporto azionario
Kairos Pharma Financials
Kairos Pharma (KAPA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
Stock Market Today: S&P 500, Nasdaq 100 Futures Slip Ahead of Data-Heavy Week, Nvidia Earnings, and Jackson Hole—BABA, PMI, BIRK in Focus
U.S. stock futures were mixed on Monday, as the Dow Jones index rose, the S&P 500 and Nasdaq 100 indices fell, after Friday's higher close.
Rishabh Mishra
Applied Optoelectronics, PDD Holdings And 3 Stocks To Watch Heading Into Monday
U.S. stock futures up, PDD, AAOI, and XPEV to report earnings, KAPA announces reverse stock split, GRRR expected to post earnings after close.
Avi Kapoor
PRO
Kairos Pharma Q4 EPS $(0.07) Beats $(0.10) Estimate
Kairos Pharma (AMEX:KAPA) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 30 percent. This is a 12.5 percent increase over losses of $(0.08) per share from the same
Benzinga Newsdesk
PRO
Kairos Pharma Q2 EPS $(0.08) Misses $(0.05) Estimate
Kairos Pharma (AMEX:KAPA) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.05) by 60 percent.
Benzinga Newsdesk
Nasdaq Gains Over 100 Points; Wells Fargo Earnings Top Views
Avi Kapoor
PRO
Kairos Pharma Q1 EPS $(0.08) Misses $(0.05) Estimate
Kairos Pharma (AMEX:KAPA) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.05) by 60 percent.
Benzinga Newsdesk
